Literature DB >> 3552240

Neuropeptide Y: intrapancreatic neuronal localization and effects on insulin secretion in the mouse.

M Pettersson, B Ahrén, I Lundquist, G Böttcher, F Sundler.   

Abstract

The intrapancreatic localization and the effects on basal and stimulated insulin secretion of neuropeptide Y (NPY) were investigated in the mouse. Immunocytochemistry showed NPY to be confined to intrapancreatic nerve fibers mainly associated with blood vessels. Fine varicose NPY fibers were also detected in the exocrine parenchyma and occasionally also within the islets. Double-staining experiments with the use of antisera for both NPY and tyrosine hydroxylase (TH) indicated that most of the NPY fibers were nonadrenergic in nature. Only a population of the NPY fibers occurring around blood vessels showed TH immunoreactivity. Under in vivo conditions, NPY was found to elevate plasma insulin levels slightly when injected intravenously at the high dose level of 8.5 nmol/kg. At lower dose levels, NPY did not affect basal plasma insulin levels, but instead inhibited glucose-induced insulin secretion. Thus, the glucose-induced increment in plasma insulin levels, which was 120 +/- 7 microU/ml in controls, was reduced to 87 +/- 5 microU/ml by NPY at 4.25 nmol/kg (p less than 0.01) and to 98 +/- 6 microU/ml by NPY at 1.06 nmol/kg (p less than 0.05). In contrast, the insulin secretory response to the cholinergic agonist carbachol was not affected by NPY. We conclude that NPY nerve fibers occur in the mouse pancreas and that most of these NPY nerve fibers are nonadrenergic. Furthermore, in the mouse, NPY enhances basal plasma insulin levels at high dose levels and inhibits glucose-induced, but not cholinergically induced insulin secretion at lower dose levels under in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552240     DOI: 10.1007/BF01239960

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  25 in total

Review 1.  Neuropeptides in the control of the islets of Langerhans.

Authors:  S M Wood; J M Polak; S R Bloom
Journal:  Adv Metab Disord       Date:  1983

Review 2.  Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans.

Authors:  R E Miller
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

3.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

4.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

5.  Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.

Authors:  E Ekblad; L Edvinsson; C Wahlestedt; R Uddman; R Håkanson; F Sundler
Journal:  Regul Pept       Date:  1984-04

6.  Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse.

Authors:  M Pettersson; B Ahrén; G Böttcher; F Sundler
Journal:  Endocrinology       Date:  1986-08       Impact factor: 4.736

7.  Neural regulation of insulin secretion in the dog.

Authors:  D Porte; L Girardier; J Seydoux; Y Kanazawa; J Posternak
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

8.  Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.

Authors:  B Ahrén; P Hedner; I Lundquist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-02

9.  Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.

Authors:  L Edvinsson; R Håkanson; S Steen; F Sundler; R Uddman; C Wahlestedt
Journal:  Regul Pept       Date:  1985-09

10.  Neuropeptide Y: direct and indirect action on insulin secretion in the rat.

Authors:  J H Moltz; J K McDonald
Journal:  Peptides       Date:  1985 Nov-Dec       Impact factor: 3.750

View more
  18 in total

1.  Sustained glucose-stimulated insulin secretion in mouse islets is not culture-dependent.

Authors:  S Carobbio; P Maechler
Journal:  Diabetologia       Date:  2004-10-22       Impact factor: 10.122

2.  A novel endocrine cell type in the guinea-pig gastric mucosa: cellular source of pro-enkephalin-derived peptides. A histochemical, immunohistochemical, and electron microscopical characterization.

Authors:  Y Cetin
Journal:  Histochemistry       Date:  1990

3.  Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.

Authors:  A Kushi; H Sasai; H Koizumi; N Takeda; M Yokoyama; M Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Plasma neuropeptide Y in impaired glucose tolerance.

Authors:  B Ahrén; H Larsson
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

5.  Beta cells are important for islet innervation: evidence from purified rat islet-cell grafts.

Authors:  U Myrsén; B Keymeulen; D G Pipeleers; F Sundler
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 6.  Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion.

Authors:  B Ahrén; G J Taborsky; D Porte
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

7.  Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity.

Authors:  L E Goehler; C Sternini
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

8.  Localization and characterization of neuropeptide Y-like peptides in the brain and islet organ of the anglerfish (Lophius americanus).

Authors:  B D Noe; S L Milgram; A Balasubramaniam; P C Andrews; J Calka; J K McDonald
Journal:  Cell Tissue Res       Date:  1989-08       Impact factor: 5.249

9.  Neuropeptide Y secretion from a human insulinoma.

Authors:  G Waeber; J Hurlimann; J A Haefliger; F Gomez; P Nicod; E Grouzmann
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

10.  Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms.

Authors:  Tara A Schwetz; Alessandro Ustione; David W Piston
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.